Found: 50
Select item for more details and to access through your institution.
Flow cytometric analysis of erythroid precursors and mutational signatures of lower risk myelodysplastic syndromes identify responders to erythroid stimulating agents.
- Published in:
- 2024
- By:
- Publication type:
- Letter
PIEZO1 mutations impact on early clinical manifestations of myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. E72, doi. 10.1002/ajh.26863
- By:
- Publication type:
- Article
Improved benefit of continuing luspatercept therapy: sub-analysis of patients with lower-risk MDS in the MEDALIST study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 311, doi. 10.1007/s00277-022-05071-8
- By:
- Publication type:
- Article
TP53‐altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single entity.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 175, doi. 10.1002/cncr.34535
- By:
- Publication type:
- Article
Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 491, doi. 10.1002/hon.2987
- By:
- Publication type:
- Article
Impact of Lenalidomide Treatment on Overall Survival in Patients With Lower-Risk, Transfusion-Dependent Myelodysplastic Syndromes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. e874, doi. 10.1016/j.clml.2022.05.001
- By:
- Publication type:
- Article
The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1474, doi. 10.1007/s12325-021-01948-8
- By:
- Publication type:
- Article
Correction to: The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Oral Azacitidine (CC-486) for the Treatment of Myeloid Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 4, p. 236, doi. 10.1016/j.clml.2021.09.021
- By:
- Publication type:
- Article
Targeting ineffective hematopoiesis in myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. 171, doi. 10.1002/ajh.26416
- By:
- Publication type:
- Article
Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the MEDALIST Phase 3 Trial.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 1, p. 27, doi. 10.3390/jcm11010027
- By:
- Publication type:
- Article
Poster: MDS-223: Response to Erythroid Stimulating Agents (ESA) and Flow Cytometric Characteristics of Bone Marrow Erythroid Precursors in IPSS-R Lower-Risk Myelodysplastic Syndrome Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S228, doi. 10.1016/S2152-2650(21)01440-3
- By:
- Publication type:
- Article
MDS-223: Response to Erythroid Stimulating Agents (ESA) and Flow Cytometric Characteristics of Bone Marrow Erythroid Precursors in IPSS-R Lower-Risk Myelodysplastic Syndrome Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S344, doi. 10.1016/S2152-2650(21)01800-0
- By:
- Publication type:
- Article
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome?
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.595838
- By:
- Publication type:
- Article
Outcome of MDS, MDS/MPN Patients Aged <65 Treated with Hypomethylating Agents as a Bridge to Transplant in a Single Tertiary-Care Italian Center.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S346, doi. 10.1016/j.clml.2019.07.354
- By:
- Publication type:
- Article
Clinical and Genetic Profiles of Young Adult Patients with Myelodysplastic Syndromes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S347, doi. 10.1016/j.clml.2019.07.355
- By:
- Publication type:
- Article
Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Does G6PD-Deficiency Related Oxidative Stress and Hemolysis Affect Erythroid Response to Erythropoietic Stimulating Agents (ESA) in Myelodysplastic Patients?.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S259, doi. 10.1016/j.clml.2018.07.168
- By:
- Publication type:
- Article
Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions: Myelodysplastic Syndromes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes: Results From the MDS-005 Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. 1037, doi. 10.1002/ajh.24842
- By:
- Publication type:
- Article
Management of Lower Risk Non-del(5q) MDS.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S35, doi. 10.1016/j.clml.2017.08.021
- By:
- Publication type:
- Article
First-line Therapeutic Strategies for Myelodysplastic Syndromes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Haploidentical bone marrow transplantation in patients with advanced myelodysplastic syndrome.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. E117, doi. 10.1002/ajh.24725
- By:
- Publication type:
- Article
Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 5, p. 1857, doi. 10.1172/JCI78752
- By:
- Publication type:
- Article
Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond ( GIMEMA MDS0306 Trial).
- Published in:
- European Journal of Haematology, 2014, v. 92, n. 6, p. 527, doi. 10.1111/ejh.12300
- By:
- Publication type:
- Article
Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes.
- Published in:
- Cytometry. Part B, 2014, v. 86B, n. 3, p. 207, doi. 10.1002/cyto.b.21160
- By:
- Publication type:
- Article
Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher-risk myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 1, p. 49, doi. 10.1111/bjh.12723
- By:
- Publication type:
- Article
A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.
- Published in:
- Cytometry. Part B, 2013, v. 84B, n. 2, p. 71, doi. 10.1002/cyto.b.21064
- By:
- Publication type:
- Article
Outcome of therapy-related myeloid neoplasms treated with azacitidine.
- Published in:
- Journal of Hematology & Oncology, 2012, v. 5, n. 1, p. 44, doi. 10.1186/1756-8722-5-44
- By:
- Publication type:
- Article
Clinical Use of Erythropoietic Stimulating Agents in Myelodysplastic Syndromes.
- Published in:
- Oncologist, 2011, v. 16, p. 35, doi. 10.1634/theoncologist.2011-S3-35
- By:
- Publication type:
- Article
Clinical Use of Erythropoietic Stimulating Agents in Myelodysplastic Syndromes.
- Published in:
- Oncologist, 2011, v. 16, p. 35, doi. 10.1634/theoncologist.2011-S3-35
- By:
- Publication type:
- Article
Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0023109
- By:
- Publication type:
- Article
Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 12, p. 2697, doi. 10.1002/cncr.25774
- By:
- Publication type:
- Article
Hammersmith score application identifies chronic myeloid leukemia patients with poor prognosis before treatment with second-generation tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 6, p. 523, doi. 10.1002/ajh.22020
- By:
- Publication type:
- Article
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 7, p. 553, doi. 10.1093/jnci/djr060
- By:
- Publication type:
- Article
Dasatinib, even at low doses, is an effective second-line therapy for chronic myeloid leukemia patients resistant or intolerant to imatinib. Results from a real life-based Italian multicenter retrospective study on 114 patients.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 12, p. 960, doi. 10.1002/ajh.21871
- By:
- Publication type:
- Article
Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 2, p. 130, doi. 10.1111/j.1600-0609.2010.01456.x
- By:
- Publication type:
- Article
Azacitidine for the Treatment of Lower Risk Myelodysplastic Syndromes: A Retrospective Study of 74 Patients Enrolled in an Italian Named Patient Program.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 6, p. 1485, doi. 10.1002/cncr.24894
- By:
- Publication type:
- Article
The addition of liposomal doxorubicin to bortezomib, thalidomide and dexamethasone significantly improves clinical outcome of advanced multiple myeloma.
- Published in:
- British Journal of Haematology, 2008, v. 141, n. 6, p. 814, doi. 10.1111/j.1365-2141.2008.07147.x
- By:
- Publication type:
- Article
The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cells.
- Published in:
- British Journal of Haematology, 2006, v. 135, n. 5, p. 653, doi. 10.1111/j.1365-2141.2006.06365.x
- By:
- Publication type:
- Article
Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts.
- Published in:
- Annals of Hematology, 2005, v. 84, p. 54, doi. 10.1007/s00277-005-0006-z
- By:
- Publication type:
- Article
Azacitidine in Myelodysplastic Syndromes: A Viewpoint by Valeria Santini.
- Published in:
- Drugs, 2005, v. 65, n. 13, p. 1790, doi. 10.2165/00003495-200565130-00005
- By:
- Publication type:
- Article
Homoharringtonine.
- Published in:
- Cancer (0008543X), 2001, v. 92, n. 6, p. 1591, doi. 10.1002/1097-0142(20010915)92:6<1591::AID-CNCR1485>3.0.CO;2-U
- By:
- Publication type:
- Article
Changes in DNA Methylation in Neoplasia: Pathophysiology and Therapeutic Implications.
- Published in:
- Annals of Internal Medicine, 2001, v. 134, n. 7, p. 573, doi. 10.7326/0003-4819-134-7-200104030-00011
- By:
- Publication type:
- Article
DIFFERENTIATION THERAPY OF MYELODYSPLASTIC SYNDROMES: FACT OR FICTION?
- Published in:
- British Journal of Haematology, 1998, v. 102, n. 5, p. 1124, doi. 10.1046/j.1365-2141.1998.00881.x
- By:
- Publication type:
- Article
Coexpression of erythroid and megakaryocytic genes in acute erythroblastic (FAB M6) and megakaryoblastic (FAB M7) leukaemias.
- Published in:
- British Journal of Haematology, 1998, v. 102, n. 5, p. 1335, doi. 10.1046/j.1365-2141.1998.00904.x
- By:
- Publication type:
- Article
Genetic lesions associated with blastic transformation of polycythemia vera and essential thrombocythemia.
- Published in:
- Genes, Chromosomes & Cancer, 1997, v. 19, n. 4, p. 250, doi. 10.1002/(SICI)1098-2264(199708)19:4<250::AID-GCC7>3.0.CO;2-W
- By:
- Publication type:
- Article
In vitro chemosensitivity testing of leukemic cells: prediction of response to chemotherapy in patients with acute non-lymphocytic leukemia.
- Published in:
- 1989
- By:
- Publication type:
- journal article
In vitro chemosensitivity testing of leukemic cells: development of a semiautomated colorimetric assay.
- Published in:
- 1989
- By:
- Publication type:
- journal article